| Amgen Likely to React Dramatically to Early FDA Approval of Osteoporosis Drug David Greene submits: After the market closed Tuesday (June 1), Amgen (Nasdaq:AMGN) announced that the FDA approved the company's osteoporosis drug, Prolia (denosumab), for post-menopausal women at risk of suffering bone fractures. The drug inhibits the destruction of bone material and increases bone strength and mass by reducing the proteins which trigger bone-destroying cells. Although the drug was approved in Europe just a few days ago, the "surprise" was that the approval was not expected until July 25 in the US. As with most new drugs, there are side effects-- back pain, high cholesterol and urinary bladder infections. However, there are some analysts that estimate the product could see annual global sales up to $3.3 billion in 2014. Oppenheimer & Co. forecasts sales of the drug for osteoporosis alone reaching more than $2 billion a year in the global market. Amgen has filed for the drug's approval in helping prevent bone complications in cancer patients with clinical data expected later this year to validate expectations that the drug also prevents prostate cancer from spreading to the bone.Complete Story » seekingalpha.com |
Scientists Build a Rat Lung Scientists have made partly functioning rat lungs in the laboratory, a small yet tantalizing step in the quest to create fresh body parts for transplantation or to treat disease. online.wsj.com |
Biogen Agrees to Develop Experimental ALS Drug Biogen Idec agreed to develop closely held Knopp Neurosciences' experimental treatment for amyotrophic lateral sclerosis, also known as Lou Gehrig's disease. online.wsj.com |
BioReference Laboratories, Inc. to Speak at the UBS Global Life Sciences Conference [Business Wire] - ELMWOOD PARK, N.J.----BioReference Laboratories, Inc. announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the 2010 UBS Global Life Sciences Conference on Monday, September 20, 2010, at The Grand Hyatt Hotel located in New York, NY. us.rd.yahoo.com |
Cochlear Implants Recalled Sonova is recalling hearing-aid implants made by its U.S. unit Advanced Bionics, a move that will hit sales and dent profits. Sonova shares slid. online.wsj.com |